CB
Chetan Bhupatray Dani
About Chetan Bhupatray Dani
Data last updated:
Chetan Bhupatray Dani is a Director at Perpetual Growth Investments Private Limited (since 2018), Director at Bezel Pharma Pvt Ltd (since 2002) and Designated Partner at Ophira Enterprise Llp (since 2021). The companies operate in Financial Services, Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹37.3 Lakh; the largest is Perpetual Growth Investments Private Limited at ₹36.3 Lakh (FY 2025). Earlier, Chetan Bhupatray Dani was a Director at Ophira Enterprise Private Limited (2019–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Perpetual Growth Investments Private Limited U67120MH1994PTC082270 | Director | 19 Jul 2018 | 1994 | ₹36.3 Lakh (FY 2025) | Active |
| Bezel Pharma Pvt Ltd U45100MH1982PTC028103 | Director | 02 Sep 2002 | 1982 | ₹93,706 (FY 2025) | Active |
| Ophira Enterprise Llp AAW-6191 | Designated Partner | 08 Apr 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Ophira Enterprise Private Limited U74999MH2017PTC297059 | Director | 17 Apr 2019 | 2017 | ₹5.59 Cr (FY 2020) | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Chetan Bhupatray Dani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sachin Navinchandra Doshi | 00259986 | Perpetual Growth Investments Private Limited , Bezel Pharma Pvt Ltd | Director |
| Rajesh Ranjit Parikh | 02527339 | Ophira Enterprise Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chetan Bhupatray Dani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chetan Bhupatray Dani
Chetan Bhupatray Dani currently holds 3 directorships: Perpetual Growth Investments Private Limited (Director, since 19 Jul 2018, revenue ₹36.3 Lakh (FY 2025)); Bezel Pharma Pvt Ltd (Director, since 02 Sep 2002, revenue ₹93,706 (FY 2025)); Ophira Enterprise Llp (Designated Partner, since 08 Apr 2021).
Chetan Bhupatray Dani was first appointed on 02 Sep 2002 as Director at Bezel Pharma Pvt Ltd. The most recent appointment on record is 08 Apr 2021 at Ophira Enterprise Llp.
The 2 current companies of Chetan Bhupatray Dani that report revenue have a combined latest revenue of ₹37.3 Lakh: Perpetual Growth Investments Private Limited ₹36.3 Lakh (FY 2025); Bezel Pharma Pvt Ltd ₹93,706 (FY 2025).
Chetan Bhupatray Dani held 1 earlier board appointment: Ophira Enterprise Private Limited (Director, 17 Apr 2019 to 07 Apr 2021).
The current boards of Chetan Bhupatray Dani's companies include Sachin Navinchandra Doshi (Perpetual Growth Investments Private Limited), Rajesh Ranjit Parikh (Ophira Enterprise Llp).